Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?

Significant research has been conducted to better understand the extensive, heterogeneous molecular features of triple-negative breast cancer (TNBC). We reviewed published TNBC molecular classifications to identify major groupings that have potential for clinical trial development. With the ultimate...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Du, Fanny, Eckhardt, Bedrich L., Lim, Bora, Litton, Jennifer K., Moulder, Stacy, Meric-Bernstam, Funda, Gonzalez-Angulo, Ana M., Ueno, Naoto T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536987/
https://www.ncbi.nlm.nih.gov/pubmed/25973541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536987/
https://www.ncbi.nlm.nih.gov/pubmed/25973541

Ejemplares similares